• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inflammatory and Anti-Inflammatory Parameters in PCOS Patients Depending on Body Mass Index: A Case-Control Study.根据体重指数分析多囊卵巢综合征患者的炎症和抗炎参数:一项病例对照研究。
Biomedicines. 2023 Oct 14;11(10):2791. doi: 10.3390/biomedicines11102791.
2
Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women.口服避孕药(OCP)治疗可改变多囊卵巢综合征(PCOS)妇女细胞间黏附分子-1(ICAM-1)、肿瘤坏死因子-α(TNF-α)、单核细胞趋化蛋白-1(MCP-1)和纤溶酶原激活物抑制剂-1(PAI-1)的基因表达,与未经药物治疗的 PCOS 妇女相比。
BMC Womens Health. 2023 Feb 15;23(1):68. doi: 10.1186/s12905-023-02187-5.
3
Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.年龄相关性白内障患者泪液中细胞因子和趋化因子浓度。
Curr Eye Res. 2020 Sep;45(9):1101-1106. doi: 10.1080/02713683.2020.1715445. Epub 2020 Jan 24.
4
Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.多囊卵巢综合征中炎症标志物的临床意义:它们与胰岛素抵抗和体重指数的关系。
Dis Markers. 2009;26(4):163-70. doi: 10.3233/DMA-2009-0627.
5
Chronic Low Grade Inflammation in Pathogenesis of PCOS.多囊卵巢综合征发病机制中的慢性低度炎症。
Int J Mol Sci. 2021 Apr 6;22(7):3789. doi: 10.3390/ijms22073789.
6
Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.多囊卵巢综合征(PCOS)患者血浆单核细胞趋化蛋白-1(MCP-1)和巨噬细胞炎性蛋白-1α水平升高,且与肥胖相关,但不受吡格列酮治疗的影响。
Clin Endocrinol (Oxf). 2009 Nov;71(5):652-8. doi: 10.1111/j.1365-2265.2009.03523.x. Epub 2009 Jan 19.
7
Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome.多囊卵巢综合征女性中的肥胖、抑郁与慢性低度炎症
Brain Behav Immun. 2008 Feb;22(2):177-84. doi: 10.1016/j.bbi.2007.07.003. Epub 2007 Aug 22.
8
Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.多囊卵巢综合征患者的血浆白细胞介素6水平升高,与肥胖或睡眠呼吸暂停无关。
Metabolism. 2006 Aug;55(8):1076-82. doi: 10.1016/j.metabol.2006.04.002.
9
The polycystic ovary syndrome per se is not associated with increased chronic inflammation.多囊卵巢综合征本身与慢性炎症增加无关。
Eur J Endocrinol. 2004 Apr;150(4):525-32. doi: 10.1530/eje.0.1500525.
10
Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome. fractalkine:多囊卵巢综合征患者中升高的炎症趋化因子。
Endocrine. 2019 Jul;65(1):175-183. doi: 10.1007/s12020-019-01972-3. Epub 2019 Jun 1.

引用本文的文献

1
Antioxidant and cytokine modulation in PCOS rats protected with probiotics, myo-inositol, and herbal extracts.益生菌、肌醇和草药提取物对多囊卵巢综合征大鼠抗氧化及细胞因子的调节作用。
Vet Med (Praha). 2025 Jun 27;70(6):203-217. doi: 10.17221/116/2024-VETMED. eCollection 2025 Jun.
2
Recognizing the Role of Insulin Resistance in Polycystic Ovary Syndrome: A Paradigm Shift from a Glucose-Centric Approach to an Insulin-Centric Model.认识胰岛素抵抗在多囊卵巢综合征中的作用:从以葡萄糖为中心的方法到以胰岛素为中心的模型的范式转变。
J Clin Med. 2025 Jun 6;14(12):4021. doi: 10.3390/jcm14124021.
3
A Systematic Review of Inflammatory Markers in Polycystic Ovary Syndrome (PCOS) and Meta-Analysis of Interleukin-6 (IL-6) in Case-Control Studies.多囊卵巢综合征(PCOS)炎症标志物的系统评价及病例对照研究中白细胞介素-6(IL-6)的荟萃分析。
Cureus. 2025 Apr 16;17(4):e82350. doi: 10.7759/cureus.82350. eCollection 2025 Apr.
4
Impact of Metformin Therapy on Chronic Inflammatory Markers Serum Fractalkine and CRP Levels in Polycystic Ovary Syndrome: A Pilot Study on Chronic Inflammatory Markers and Clinical Outcomes.二甲双胍治疗对多囊卵巢综合征慢性炎症标志物血清趋化因子和CRP水平的影响:关于慢性炎症标志物与临床结局的一项初步研究
J Obstet Gynaecol India. 2025 Apr;75(2):115-121. doi: 10.1007/s13224-025-02100-0. Epub 2025 Feb 13.
5
The role of immunity in insulin resistance in patients with polycystic ovary syndrome.免疫在多囊卵巢综合征患者胰岛素抵抗中的作用。
Front Endocrinol (Lausanne). 2025 Jan 22;15:1464561. doi: 10.3389/fendo.2024.1464561. eCollection 2024.
6
T cells are necessary for development of PCOS reproductive symptoms in a letrozole-induced mouse model of PCOS.在来曲唑诱导的多囊卵巢综合征小鼠模型中,T细胞对于多囊卵巢综合征生殖症状的发展是必需的。
bioRxiv. 2025 Jan 13:2025.01.08.631835. doi: 10.1101/2025.01.08.631835.
7
Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome.患有和未患有多囊卵巢综合征的女性的心血管风险生物标志物
Biomolecules. 2024 Dec 24;15(1):4. doi: 10.3390/biom15010004.
8
Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome.多囊卵巢综合征中的系统性低度慢性炎症及内在机制
Front Immunol. 2024 Dec 19;15:1470283. doi: 10.3389/fimmu.2024.1470283. eCollection 2024.
9
Genetically predicted serum metabolites mediate the association between inflammatory proteins and polycystic ovary syndrome: a Mendelian randomization study.基因预测的血清代谢物介导炎症蛋白与多囊卵巢综合征之间的关联:一项孟德尔随机化研究。
Front Med (Lausanne). 2024 Dec 3;11:1433612. doi: 10.3389/fmed.2024.1433612. eCollection 2024.
10
Mesenchymal Stromal Cell Exosome-Induced Vascular Regeneration in a PCOS Mouse Model.间充质基质细胞外泌体诱导多囊卵巢综合征小鼠模型中的血管再生
Reprod Sci. 2025 Mar;32(3):825-835. doi: 10.1007/s43032-024-01720-7. Epub 2024 Oct 15.

本文引用的文献

1
The World according to IL-9.《白细胞介素-9 世界》
J Immunol. 2023 Jul 1;211(1):7-14. doi: 10.4049/jimmunol.2300094.
2
The interplay between androgens and the immune response in polycystic ovary syndrome.雄激素与多囊卵巢综合征免疫反应的相互作用。
J Transl Med. 2023 Apr 16;21(1):259. doi: 10.1186/s12967-023-04116-4.
3
Interleukin-22/Interleukin-22 binding protein axis and oral contraceptive use in polycystic ovary syndrome.白细胞介素-22/白细胞介素-22 结合蛋白轴与多囊卵巢综合征患者的口服避孕药使用。
Endocrine. 2023 Jul;81(1):54-57. doi: 10.1007/s12020-023-03360-4. Epub 2023 Apr 4.
4
The Association Between Increment of Interleukin-1 and Interleukin-6 in Women with Polycystic Ovary Syndrome and Body Mass Index.多囊卵巢综合征女性白细胞介素-1和白细胞介素-6增量与体重指数之间的关联
J Reprod Infertil. 2023 Jan-Mar;24(1):26-34. doi: 10.18502/jri.v24i1.11906.
5
The alterations of circulating mucosal-associated invariant T cells in polycystic ovary syndrome.多囊卵巢综合征患者循环黏膜相关不变 T 细胞的改变。
Front Endocrinol (Lausanne). 2022 Nov 28;13:1038184. doi: 10.3389/fendo.2022.1038184. eCollection 2022.
6
The Association Between Genetically Predicted Systemic Inflammatory Regulators and Polycystic Ovary Syndrome: A Mendelian Randomization Study.基于遗传预测的系统性炎症调节因子与多囊卵巢综合征的相关性:一项孟德尔随机化研究。
Front Endocrinol (Lausanne). 2021 Sep 27;12:731569. doi: 10.3389/fendo.2021.731569. eCollection 2021.
7
MIG/CXCL9 exacerbates the progression of metabolic-associated fatty liver disease by disrupting Treg/Th17 balance.MIG/CXCL9 通过破坏 Treg/Th17 平衡加剧代谢相关脂肪性肝病的进展。
Exp Cell Res. 2021 Oct 15;407(2):112801. doi: 10.1016/j.yexcr.2021.112801. Epub 2021 Aug 27.
8
The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis.慢性炎症在多囊卵巢综合征中的作用:系统评价和荟萃分析。
Int J Mol Sci. 2021 Mar 8;22(5):2734. doi: 10.3390/ijms22052734.
9
Association of circulating monocyte chemoattractant protein-1 levels with polycystic ovary syndrome: A meta-analysis.循环单核细胞趋化蛋白-1 水平与多囊卵巢综合征的相关性:一项荟萃分析。
Am J Reprod Immunol. 2021 Aug;86(2):e13407. doi: 10.1111/aji.13407. Epub 2021 Mar 9.
10
Endocrine disruptors, obesity, and cytokines - how relevant are they to PCOS?内分泌干扰物、肥胖和细胞因子——它们与 PCOS 有何关联?
Physiol Res. 2020 Sep 30;69(Suppl 2):S279-S293. doi: 10.33549/physiolres.934521.

根据体重指数分析多囊卵巢综合征患者的炎症和抗炎参数:一项病例对照研究。

Inflammatory and Anti-Inflammatory Parameters in PCOS Patients Depending on Body Mass Index: A Case-Control Study.

作者信息

Vasyukova Elena, Zaikova Ekaterina, Kalinina Olga, Gorelova Inga, Pyanova Irina, Bogatyreva Elena, Vasilieva Elena, Grineva Elena, Popova Polina

机构信息

Institute of Endocrinology, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.

World-Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, 194156 Saint Petersburg, Russia.

出版信息

Biomedicines. 2023 Oct 14;11(10):2791. doi: 10.3390/biomedicines11102791.

DOI:10.3390/biomedicines11102791
PMID:37893164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10604137/
Abstract

BACKGROUND

it has been suggested that chronic low-grade inflammation plays an important role in the pathogenesis of polycystic ovary syndrome (PCOS). According to previous studies, it remains unclear which cytokines influence the development of this syndrome and whether their increase is associated with the presence of excess weight/obesity or is an independent factor. The aim of our research was to determine the parameters of chronic inflammation in women with PCOS in comparison with healthy women in the normal weight and the overweight subgroups.

METHODS

This case-control study included 44 patients with PCOS (19 women with a body mass index (BMI) < 25 kg/m² and 25 women with a BMI ≥ 25 kg/m²) and 45 women without symptoms of PCOS (22 women with a BMI < 25 kg/m² and 23 women with a BMI ≥ 25 kg/m²). Thirty-two cytokines were analyzed in the plasma of the participants using Immunology multiplex assay HCYTA-60K-PX48 (Merck Life Science, LLC, Germany).

RESULTS

Cytokines: interleukin-1 receptor antagonist (IL-1 RA), IL-2, IL-6, IL-17 E, IL-17 A, IL-18, and macrophage inflammatory protein-1 alpha (MIP-1 α) were increased in women with PCOS compared to controls, both in lean and overweight/obese subgroups ( < 0.05). Moreover, only lean women with PCOS had higher levels of IL-1 alpha, IL-4, IL-9, IL-12, IL-13, IL-15, tumor necrosis factor (TNF- α) alpha and beta, soluble CD40 and its ligand (SCD40L), fractalkine (FKN), monocyte-chemotactic protein 3 (MCP-3), and MIP-1 β compared to the control group ( < 0.05). IL-22 was increased in the combined group of women with PCOS (lean and overweight/obese) compared to the control group ( = 0.012).

CONCLUSION

Chronic low-grade inflammation is an independent factor affecting the occurrence of PCOS and does not depend on the presence of excess weight/obesity. For the first time, we obtained data on the increase in such inflammatory parameters as IL-9, MCP-3, and MIP-1α in women with PCOS.

摘要

背景

有人提出慢性低度炎症在多囊卵巢综合征(PCOS)的发病机制中起重要作用。根据以往研究,尚不清楚哪些细胞因子会影响该综合征的发展,以及它们的增加是否与超重/肥胖的存在有关,或者是否是一个独立因素。我们研究的目的是确定PCOS女性与正常体重和超重亚组的健康女性相比的慢性炎症参数。

方法

这项病例对照研究纳入了44例PCOS患者(19例体重指数(BMI)<25kg/m²的女性和25例BMI≥25kg/m²的女性)以及45例无PCOS症状的女性(22例BMI<25kg/m²的女性和23例BMI≥25kg/m²的女性)。使用免疫 multiplex 分析HCYTA - 60K - PX48(德国默克生命科学有限责任公司)对参与者血浆中的32种细胞因子进行分析。

结果

与对照组相比,PCOS女性的细胞因子:白细胞介素 - 1受体拮抗剂(IL - 1RA)、IL - 2、IL - 6、IL - 17E、IL - 17A、IL - 18和巨噬细胞炎性蛋白 - 1α(MIP - 1α)均升高,在瘦型和超重/肥胖亚组中均如此(P<0.05)。此外,仅PCOS瘦型女性的IL - 1α、IL - 4、IL - 9、IL - 12、IL - 13、IL - 15、肿瘤坏死因子(TNF - α)α和β、可溶性CD40及其配体(SCD40L)、fractalkine(FKN)、单核细胞趋化蛋白3(MCP - 3)和MIP - 1β水平高于对照组(P<0.05)。与对照组相比,PCOS女性(瘦型和超重/肥胖)合并组的IL - 22升高(P = 0.012)。

结论

慢性低度炎症是影响PCOS发生的独立因素,且不依赖于超重/肥胖的存在。我们首次获得了PCOS女性中IL - 9、MCP - 3和MIP - 1α等炎症参数升高的数据。